Ffion Davies(@iamffionhd) 's Twitter Profile Photo

Popping the libre arm cherry. Next 14 days are all about avoiding doorframes and agressive toweling & jacket dressing. Any tips welcome…. 💙

Popping the libre arm cherry. Next 14 days are all about avoiding doorframes and agressive toweling & jacket dressing. Any tips welcome…. 💙 #libre #diabetestech #gbdoc
account_circle
Enhance-d(@enhance_d) 's Twitter Profile Photo

🚀 We're thrilled to announce the launch of our new digital diabetes management tool! 🎉
You can Sign-Up now for a 14-day FREE TRIAL (no commitment or credit card needed) here: eu1.hubs.ly/H04TLt30
Tech

🚀 We're thrilled to announce the launch of our new digital diabetes management tool! 🎉
You can Sign-Up now for a 14-day FREE TRIAL (no commitment or credit card needed) here: eu1.hubs.ly/H04TLt30
#Diabetes #T1D #T2D #DiabetesTech #startup #innovation #DigitalHealth
account_circle
joe aloi(@josephaloi) 's Twitter Profile Photo

Join us on December 4, 2023, 1-2 pm EST in 2023! Don't miss this 🔗Register: Link [professionaleducation.diabetes.org]
Hybrid Closed-Loop Systems, Insulin Pens, and Continuous Glucose Monitors.

Join us on December 4, 2023, 1-2 pm EST #DiabetesTech in 2023! Don't miss this  🔗Register: Link [professionaleducation.diabetes.org]
Hybrid Closed-Loop Systems, Insulin Pens, and Continuous Glucose Monitors.
account_circle
Dr Amar Puttanna 🎸(@AmarPut) 's Twitter Profile Photo

📣Children&young people with T1D & parents! Do you or your child face struggle to get tech for T1D? Share your story in an interview(for £25 each) Help understand why some people are missing out on life-changing T1D tech. Contact: [email protected]

account_circle
Ascensia Diabetes Care(@AscensiaGlobal) 's Twitter Profile Photo

Day 2 at ! We'll be at Booth 13A talking all about the Eversense E3 - The only long-term CGM. Stop by to learn about how the Eversense E3 is the CGM that offers reliability, flexibility and convenience Tech

Day 2 at #ATTD2024! We'll be at Booth 13A talking all about the Eversense E3 - The only long-term CGM. Stop by to learn about how the Eversense E3 is the CGM that offers reliability, flexibility and convenience #ATTD2024 #Diabetes #DiabetesTech #EversenseE3 #CGM
account_circle
Mike Hughes(@mikehughes0) 's Twitter Profile Photo

Excited to be included with Stanford Endocrinology Rayhan Lal in the 2023 Annual Report: bit.ly/46FiJqD

And feeling inspired by so many of the other stories from Stanford Department of Medicine! 🤩 domannualreports.stanford.edu/2023-annual-re… , tech, , ,

Excited to be included with @StanfordEndo Rayhan Lal in the #StanDOM 2023 Annual Report: bit.ly/46FiJqD

And feeling inspired by so many of the other stories from @StanfordDeptMed! 🤩 domannualreports.stanford.edu/2023-annual-re… #diabetes, #diabetestech, #CGM, #closedloop, #Inpatientdiabetes
account_circle
Jurgen Vercauteren(@vercauteren_jur) 's Twitter Profile Photo

En route to in Florence! Glucose buzzing with excitement. ATTD: central for diabetes tech and treatments. Thrilled to bridge R&D and real-world impact as T1D researcher and patient.

En route to #ATTD in Florence! Glucose buzzing with excitement. ATTD: central for diabetes tech and treatments. Thrilled to bridge R&D and real-world impact as T1D researcher and patient. #DiabetesTech #T1D
account_circle
EASD(@EASDnews) 's Twitter Profile Photo

ATTD Expert Insights ep.3: Partha Kar paints a path to closing the disparities gap in . Watch the full episode to discover how to take on the challenge to make available for everybody: easd-elearning.eu/ATTD_Expert_In…

account_circle